相关实验视频
Updated: May 16, 2025

11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
94.2K
在全身性硬化症患者中的ADAMTS13和胰岛素耐药性
Iván Ferraz-Amaro1, Zena Ibrahim-Achi2, Antonia de Vera-González3
1Department of Internal Medicine. University of La Laguna (ULL), Tenerife, and Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. iferrazamaro@hotmail.com.
Clinical and experimental rheumatology
|May 15, 2025
概括
系统性硬化症 (SSc) 患者的ADAMTS13水平较低. 这些水平与SSc中的胰岛素抵抗有积极的相关性,突出显示了自身免疫性疾病和代谢功能障碍之间的联系.
科学领域:
- 自体免疫学 自体免疫学
- 血管生物学 血管生物学
- 代谢综合征是代谢综合征的一种.
背景情况:
- 像系统性硬化症 (SSc) 这样的自身免疫性疾病会影响新陈代谢和血管健康.
- ADAMTS13在血管平衡中起作用,其水平可能在SSc.中发生变化.
研究的目的:
- 为了研究ADAMTS13,SSc和胰岛素抵抗之间的关系.
- 探索ADAMTS13与SSc患者疾病特征和心脏代谢特征的关联.
主要方法:
- 一项横截面研究将81名SSc患者与76名健康对照进行了比较.
- 测量了血清ADAMTS13,脂质样本和胰岛素抵抗指数.
- 用多变量线性回归分析来评估关联.
主要成果:
- 与对照组相比,SSc患者的ADAMTS13血清水平明显较低.
- ADAMTS13水平与C反应性蛋白负相关.
- 在SSc患者中,ADAMTS13水平和胰岛素抵抗之间发现了积极的关联.
结论:
- 在SSc患者中,ADAMTS13血清水平下降.
- 在SSc中,ADAMTS13水平和胰岛素抵抗之间存在正相关性.
- 这些发现表明ADAMTS13功能障碍,SSc和代谢变化之间存在联系.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
142
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
142
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Insulin: Dosing Regimen and Adverse Effects
129
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
129
Carbohydrate Metabolism
10.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.6K
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Insulin: The Receptor and Signaling Pathways
1.0K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.0K

